Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Acupuncture plus standard therapy for passing ureteral stones

Official title: Evaluation of the Effectiveness of Acupuncture Application in Addition to Medical Expulsive Therapy for Ureteral Stones

Run by Hitit University · NCT07893431 · Data updated 2026-11-12

This study tests whether adding acupuncture to standard medical therapy helps people with small ureteral stones pass the stone more quickly.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment40 (estimated)
SponsorHitit University
Academic / other
Locations1 site (Çorum, Çorum)
StatusRecruiting
StartedAugust 1, 2026
Main results expectedApril 8, 2027
Study endsApril 30, 2027
Registry record updatedOctober 26, 2026
Trial IDNCT07893431 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with radiologically confirmed unilateral distal or mid-ureteral stones 3–10 mm suitable for conservative treatment.

Probably not a fit

Patients with stones larger than 10 mm, infection, renal impairment, pregnancy, solitary kidney, or recent stone intervention may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, non-randomized study will compare two groups of adults with unilateral 3–10 mm distal or mid-ureteral stones: standard medical expulsive therapy (tamsulosin) alone versus acupuncture added to MET. Over 10 days, researchers will track stone passage, time to passage, pain levels, and analgesic use. Stone passage will be confirmed by patient report and imaging as needed, with statistical methods used to compare outcomes between groups. The trial is sponsored by Hitit University and will be conducted at Hitit University in Çorum, Turkey.

Why it matters

Potential benefit: If successful, adding acupuncture to MET could increase the likelihood of spontaneous stone passage and reduce pain and analgesic needs.

How similar studies have gone: Prior studies in this area have explored MET with adjuncts; non-randomized evidence exists but robust randomized data are limited, making results exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients aged 18-65 years.
2. Patients with a radiologically confirmed unilateral ureteral stone.
3. Stone size between 3 and 10 mm.
4. Patients with a distal or mid-ureteral stone.
5. Patients with a clinical condition suitable for conservative treatment.
6. Patients who provide written informed consent to participate in the study.

Exclusion Criteria:

1. Stone size \>10 mm or clinical conditions requiring surgical/endoscopic intervention.
2. Fever, urinary tract infection, or signs of sepsis.
3. Severe hydronephrosis or renal dysfunction.
4. Pregnancy.
5. Solitary kidney or bilateral urinary tract obstruction.
6. Previous intervention for the current ureteral stone.
7. Bleeding diathesis or anticoagulant therapy that constitutes a contraindication to acupuncture.
8. Dermatological or systemic diseases that prevent acupuncture application.
9. Patients who are unable to comply with the study protocol or follow-up.

Where it's running

  • Hitit university
    Çorum, Çorum, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.